Search for: "N. LILLY" Results 41 - 60 of 268
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2007, 5:37 pm
- and here's the website of his immigration court.)The BBC further explained what a tangled web we weave, when first we practice to hire servants on the fiddle and then have sex with them:[O]n appeal she was cleared of blackmailing 61-year-old Judge Khan, with whom she had an affair and had been living with until her arrest.The exact grounds for appeal cannot be reported except that it was on the basis of new evidence.Both judges had been employing Driza… [read post]
27 Apr 2022, 8:20 am
 The neighbourhood bears the name of Agustín Argüelles, the legal guardian of Queen Isabella II. [read post]
27 Dec 2012, 7:50 am by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
17 Sep 2010, 7:33 am by Will
” Id.(4) And just to throw another monkey-wrench in the causal chain: “[I]n practice, TPPs rarely modify the recommendations of their PBMs. [read post]
9 Feb 2010, 3:52 am by sally
Court of Appeal (Criminal Division) Curtis v R [2010] EWCA Crim 123 (09 February 2010) Court of Appeal (Civil Division) O’Beirne v Hudson [2010] EWCA Civ 52 (09 February 2010) Drew v Whitbread [2010] EWCA Civ 53 (09 February 2010) B, R (on the application of) v Cornwall Council & Anor [2010] EWCA Civ 55 (09 February 2010) W (Children), Re [2010] EWCA Civ 57 (09 February 2010) Eli Lilly & Co v Human Genome Sciences Inc [2010] EWCA Civ 33 (09 February 2010) D (Children), Re… [read post]
31 Aug 2010, 10:01 pm by Kelly
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of generic Strattera: Eli… [read post]
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
13 May 2015, 4:00 am by Administrator
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
5 May 2015, 12:12 pm by Kali Borkoski
McMahon with its Erwin N. [read post]